Sarepta Therapeutics Inc. (SRPT)
Market Closed
19 Oct, 08:00 PM
$
17. 73
+0.63
+3.6842%
$
1.81B Market Cap
- P/E Ratio
- Div Yield
2.33M Volume
-6.99 Eps
$ 17.1
Previous Close 
Want to track SRPT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sarepta Therapeutics stock to enter S&P MidCap 400: Should you buy?
Sarepta Therapeutics (NASDAQ:SRPT) is set to make a significant move by entering the S&P MidCap 400 index, replacing Shockwave Medical. This change, effective before trading begins on June 3, 2024, follows Johnson & Johnson's acquisition of Shockwave Medical.
Invezz | 2 years ago
2026 © Marketlog. All Rights Reserved.
